Cited by 138Advanced Glycation End Products researchNitric Oxide and Endothelin EffectsChronic Kidney Disease and Diabetes

Impact of advanced glycation end products (AGEs) signaling in coronary artery disease

Open access
Kosmopoulos, Marinos, Drekolias, Dimitrios, Zavras, Phaedon D., Piperi, Christina, Papavassiliou, Athanasios G.·2019·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract

Coronary artery disease remains the leading cause of mortality in adult diabetic population with however, a high predominance also in non-diabetic subjects. In search of common molecular mechanisms and metabolic by-products with potential pathogenic role, increased advanced glycation end products (AGEs) present a critical biomarker for CAD development in both cases. Interaction of AGEs with their transmembrane cell receptor, RAGE in endothelial and smooth muscle cells as well as in platelets, activates intracellular signaling that leads to endothelial injury, modulation of vascular smooth muscle cell function and altered platelet activity. Furthermore, tissue accumulation of AGEs affects current treatment approaches being involved in stent restenosis. The present review provides an update of AGE-induced molecular mechanisms involved in CAD pathophysiology while it discusses emerging therapeutic interventions targeting AGE reduction and AGE-RAGE signaling with beneficial clinical outcome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2019.01.006

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 103 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kosmopoulos, M., Drekolias, D., Zavras, P. D., Piperi, C., & Papavassiliou, A. G.
Affiliations
National and Kapodistrian University of Athens (GR)
Corresponding author
  • Piperi, Christina
  • Papavassiliou, Athanasios G.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2019-03
Volume
1865
Issue
3
Pages
611-619
ISSN
0925-4439 (ISSN-L)
OpenAlex
W2907553212
Cited by
136
References
103
Citations by year
2026: 15 · 2025: 22 · 2024: 20 · 2023: 27 · 2022: 21 · 2021: 14 · 2020: 11 · 2019: 5 · 2018: 1
FWCI
1.66
Type
journal article
Language
en
Open access
Locations
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
advanced glycation end products, RAGE, receptor for advanced glycation end products, coronary artery disease, AGE-RAGE signaling pathway, endothelial injury, vascular smooth muscle cells, platelet activation, in-stent restenosis, diabetic cardiovascular disease, biomarkers
MeSH terms
Receptor for Advanced Glycation End Products, Animals, Coronary Artery Disease, Humans, Signal Transduction, Glycation End Products, Advanced, Oxidative Stress, Myocytes, Smooth Muscle, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review